key: cord-0820354-gg1ae7hq
authors: Guo, Wei; Ming, Fangzhao; Feng, Yong; Zhang, Qian; Mo, Pingzhen; Liu, Lian; Gao, Ming; Tang, Weiming; Liang, Ke
title: Patterns of HIV and SARS‐CoV‐2 co‐infection in Wuhan, China
date: 2020-06-15
journal: J Int AIDS Soc
DOI: 10.1002/jia2.25568
sha: 0dce88b8eff0ff65affca29ed006a870d1797704
doc_id: 820354
cord_uid: gg1ae7hq

People living with HIV/AIDS (PLWHA) were initially considered to be at an increased risk of infection with SARS‐CoV‐2 due to their risk of immunosuppresion(1). However, few studies have reported on co‐infections between HIV and SARS‐CoV‐2 and treatment outcomes, and data to date do not support either increased acquisition or severity of COVID‐19.

This article is protected by copyright. All rights reserved People living with HIV/AIDS (PLWHA) were initially considered to be at an increased risk of infection with SARS-CoV-2 due to their risk of immunosuppresion 1 . However, few studies have reported on co-infections between HIV and SARS-CoV-2 and treatment outcomes, and data to date do not support either increased acquisition or severity of COVID-19 2,3 . Here we present the clinical and laboratory patterns in 14 co-infected cases, including three asymptomatic SARS-CoV-2 carriers in Wuhan, China, from February 16 th to April 30 th , 2020.

The 14 cases were coded P1 to P14 in order of their infection severity, namely: critical (P1 and P2), severe (P3 to P5), mild (P6 to P11), and asymptomatic (P12 to P14) (table). The case group consisted of 13 men who have sex with men (MSM) and one heterosexual female. Only P10 and P13 had smoking history, and none of them abused alcohol.

The median age of the COVID-19 patients was 56 (range 31 to 71 years old), while the three SARS-CoV-2 carriers were 24, 57, and 64 years old. Five patients had hypertension and were on anti-hypertensive agents.

Ten patients and two asymptomatic carriers showed undetectable HIV viral load (HIV-VL) and CD4+ T lymphocyte count (CD4 count) between 141-817/µL prior to SARS-CoV-2 co-infection.

Two HIV-VL unsuppressed individuals included patient (P5) who presented with a CD4 count of 34/µL without having ever received antiretroviral therapy (ART), and an asymptomatic carrier (P12) who presented with a CD4 count of 29/µL after two weeks of ART. Four co-morbidity cases presented with a CD4 count less than 200/µL, including two severe cases and two mild cases (All recovered at the end of the study). Although P12 presented with a low CD4 count, he did not even show any symptoms of COVID-19 or any abnormality in the radiograph. This may indicate that low CD4 count did not inevitably lead to death under HIV and SARS-CoV-2 co-infection. On the contrary, the two deaths occurred in cases who had a relatively high CD4 count (350/µL and 695/µL). This finding is consistent with a previous study, which reported one AIDS/COVID-19 patient who presented a low CD4 count (13/µL) and recovered finally 2 . Considering that

This article is protected by copyright. All rights reserved SARS-CoV-2 might cause multi-organ injury through the inflammatory cytokine storm 4 , we hypothesized that previous low CD4 count might act a protective role in preventing hyperimmune response. However, our sample size limits the deduction for a generalized conclusion, and hence large-scale investigation are needed to validate this hypothesis.

The proportion of severe cases (5/11, 45.5%) was higher among the case series than reported in the general population 5 . The COVID-19 mortality rate (18.2%) was also higher than the overall COVID-19 mortality (7.7%, 3869/50333) in Wuhan 6 . The median age among the co-infected cases was older than that of overall patients, and the higher proportion of comorbidities in our Latest HIV-VL (copies/mL) <20 <20 <20 <20 35600 <20 <20 <20 <20 <20 <20 -<20 452

Diagnosis Symptoms - 

Maintaining HIV care during the COVID-19 pandemic. The lancet HIV 2020

COVID-19 in patients with HIV: clinical case series. The Lancet HIV 2020

Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city

COVID-19: immunopathology and its implications for therapy

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Clinical Characteristics of Coronavirus Disease 2019 in China